PRESERFLO MicroShunt in Severe Myopia: A Case Report and Review of the Literature
Klinische Monatsblätter für Augenheilkunde · 01.04.2024 · 241 (04) · 361-366
DOI: 10.1055/a-2239-0636 ↗Kurz gefasst
Fallbericht in der Zeitschrift Klinische Monatsblätter für Augenheilkunde, erschienen am 01.04.2024. Verfasst von Jérôme George und 1 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology, University of Geneva, Faculty of Medicine, Geneva, Switzerland. Hauptthemen laut MEDLINE: Glaucoma, Open-Angle. Die Arbeit nennt 39 Literaturangaben.
Abstract (Originalsprache)
The PRESERFLO™ MicroShunt (MP; Santen Inc., Osaka, Japan) is a minimally invasive bleb surgery (MIBS) manufactured to treat primary open-angle glaucoma (POAG), with lower postoperative adverse effects than with conventional filtering surgeries. We describe here the case study of a 58-year-old woman who presented with bilateral severe myopia with bilateral advanced POAG and unreached target pressure under quadritherapy, who was successfully managed by PM surgery. A review of the literature completes our observation. At presentation, the patient had a spherical equivalent of − 7.50 RE and − 7.75 LE with an IOP of 22 mmHg right and left eye (RLE) under quadritherapy, and with severe bilateral visual field loss, including scotomas within the central 5°. The patient presented with systemic hypertension treated with an antihypertensive drug. Two selective laser trabeculoplasties (SLT), performed 3 months apart, were first tried on the LE, without any change in IOP at 2 months. After considering the high risk of postoperative complications, a PM operation was proposed, with a targeted IOP in the mid-fifteens RLE. The patientʼs eyes underwent PM surgery with mitomycin C (MMC) MMC0.2 mg/mL for 3 minutes without any complications. The LE required 2 consecutive needlings with 1 mL MMC0.2 mg/mL. At 24 months after surgery, the two eyes gave successful results without the need for any additional medical therapy, and with well-functioning conjunctival blebs. The PM was an effective alternative to the gold standard trabeculectomy in our severely myopic patient. A comparative study between conventional filtering operations and this MIBS in highly myopic patients would confirm our observation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Ophthalmology, University of Geneva, Faculty of Medicine, Geneva, Switzerland.
ORCID-Profile: Jérôme George
Zitieren
APA
George, J., & Abouzeid, H. (2024). PRESERFLO MicroShunt in Severe Myopia: A Case Report and Review of the Literature. Klinische Monatsblätter für Augenheilkunde, 241(04), 361-366. https://doi.org/10.1055/a-2239-0636
Vancouver
George J, Abouzeid H. PRESERFLO MicroShunt in Severe Myopia: A Case Report and Review of the Literature. Klinische Monatsblätter für Augenheilkunde. 2024;241(04):361-366. doi:10.1055/a-2239-0636
BibTeX
@article{George2024,
author = {George, Jérôme and Abouzeid, Hana},
title = {PRESERFLO MicroShunt in Severe Myopia: A Case Report and Review of the Literature},
journal = {Klinische Monatsblätter für Augenheilkunde},
year = {2024},
volume = {241},
number = {04},
pages = {361--366},
doi = {10.1055/a-2239-0636}
}
EUVIMED